What is the recommended treatment for a patient who has passed an Ascaris (roundworm) in their stool?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ascaris Lumbricoides (Roundworm) in Stool

A single oral dose of albendazole 400 mg is the recommended first-line treatment for a patient who has passed an Ascaris worm in their stool. 1

First-Line Treatment Options

You have three equally effective single-dose options for treating confirmed ascariasis:

  • Albendazole 400 mg orally once 2, 1
  • Mebendazole 500 mg orally once 2, 1
  • Ivermectin 200 μg/kg orally once 2, 1

All three medications achieve approximately 93% parasitological cure rates within 14-60 days and are considered therapeutically equivalent. 3 The choice between them is primarily based on local availability and cost, as no clinically meaningful differences in efficacy or safety have been detected. 3

Alternative Mebendazole Dosing

If using the standard mebendazole formulation (100 mg tablets), the FDA-approved regimen is 100 mg twice daily for 3 consecutive days. 4 This multi-day regimen achieves similar cure rates to the single 500 mg dose. 3

Key Clinical Points

Treatment is indicated even in asymptomatic patients to prevent serious complications including intestinal obstruction (especially in children), biliary obstruction, and migration-related issues. 5

No special preparation is required - no fasting, purging, or bowel preparation is necessary before or after treatment. 4

The medication can be administered flexibly - tablets may be chewed, swallowed whole, or crushed and mixed with food. 4

When to Retreat

If the patient is not cured three weeks after initial treatment, administer a second identical course. 4 Treatment failure rates range from 0-30% depending on infection intensity and individual factors. 3

Monitoring and Follow-Up

Confirm cure by stool microscopy 3-4 weeks post-treatment if clinically indicated, though routine follow-up is not necessary for uncomplicated cases in asymptomatic patients. 1

Watch for persistent symptoms that might indicate complications requiring surgical intervention, particularly intestinal or biliary obstruction. 1

Safety Profile

All three anthelmintic options are well-tolerated. 3 The most commonly reported adverse events are mild and self-limited:

  • Nausea and vomiting 3
  • Abdominal pain 3
  • Diarrhea 3
  • Headache 3
  • Fever 3

No serious adverse events have been reported in clinical trials comparing these medications for ascariasis. 3

Special Populations

Pregnant women should receive pyrantel pamoate (11 mg/kg as a single dose, maximum 1 g) rather than albendazole or mebendazole due to teratogenicity concerns. 5

Children and adults receive the same dosing - the 400 mg albendazole or 500 mg mebendazole single dose applies across all age groups. 2, 4

Clinical Pitfall to Avoid

Do not delay treatment waiting for stool microscopy confirmation if an adult worm has been visualized - direct visualization of the characteristic earthworm-sized white adult worm passed in stool is diagnostic and sufficient to initiate treatment immediately. 2

References

Guideline

Treatment of Ascaris Lumbricoides Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anthelmintic drugs for treating ascariasis.

The Cochrane database of systematic reviews, 2020

Research

Human Ascariasis: An Updated Review.

Recent patents on inflammation & allergy drug discovery, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.